Selected Cell
Cell:
Value:
Metadata
Samples
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| Datafile metadata | How to use this sheet Details on how to use this sheet and what the cells mean can be found by visiting: | ||||||||
| Data File Title: | samples-publish2023-05-16_11-38.xlsx | ||||||||
| Data File Description: | Batch sample publishing | ||||||||
| Project SEEK ID: | https://fairdomhub.org/projects/340 | ||||||||
| Master metadata sheet guide | |||||||||
| Associated Assay | |||||||||
| Existing Assay SEEK ID: | https://fairdomhub.org/assays/2113 | ||||||||
| OR | |||||||||
| New Assay metadata | |||||||||
| Study SEEK ID: | |||||||||
| Assay Title: | |||||||||
| Assay Description: | |||||||||
| Assay type: | Experimental_assay_type | Powered by: | |||||||
| Technology type: | Technology_type | ||||||||
| SOP SEEK ID: | |||||||||
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | Name | Parent | Type | Stimulation | Scientist | Protocol | Protocol_Device | Material | |
| OOC-230201KAM-1 | Fibrin Clots Control 0% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 0% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-2 | Fibrin Clots 5% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 5% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-3 | Fibrin Clots 25% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-4 | Fibrin Clots 50% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 50% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-5 | Beads Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 0% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-6 | Beads 5% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 5% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-7 | Beads 25% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-8 | Beads 50% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 50% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-10 | Fibrin Clots 25% and Dextran | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 25% Plasma; Dextran | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-11 | MDA-MB-231 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-12 | MDA-MB-231 Extravasation Fibrinogen | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-13 | MDA-MB-231 Extravasation Thrombin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-14 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 antibody | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 antibody | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-15 | MDA-MB-231 Extravasation Thrombin and anti-PAR1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Thrombin; PM2 | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-16 | SKBR3 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-17 | SKBR3 Extravasation Fibrinogen | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Fibrinogen | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-18 | MCF7 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230201KAM-19 | MCF7 Extravasation Thrombin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230207KAM-1 | MDA-MB-231 Extravasation Fibrin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | 10% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230207KAM-2 | Permeability Baseline | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Control | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230207KAM-3 | Permeability Thrombin | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230207KAM-5 | Permeability 25% Plasma | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Permeability | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-1 | Permeability Cold Control | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Cold Control | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-2 | MDA-MB-231 Extravasation Fibrinogen and siRNA scramble control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; scramble siRNA negative control | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-3 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 siRNA1 | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-4 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA2 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 siRNA2 | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-5 | Platelet clots | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230217KAM-1 | Clot Formation | 10% Plasma with platelets | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-6 | MCF7 Extravasation Thrombin and anti-PAR1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Thrombin; PM2 | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
| OOC-230217KAM-7 | SKBR3 Extravasation Fibrinogen and anti-ICAM1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 antibody | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane | |
